Home » Topics » Regulatory » EMA

EMA
RSS

FDA and EMA grant orphan drug status to ImmunoGen's IMGN-901 in MCC

March 9, 2010

EMA accepts voclosporin for regulatory review

March 3, 2010

Ariad's AP-24534 receives orphan drug status for CML

March 2, 2010

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

EMA approves OncoGenex's development plan for OGX-011

Feb. 26, 2010

Rare Disease Day 2010 focuses attention on orphan drug development

Feb. 26, 2010

CHMP adopts positive opinion on marketing of GSK's pandemic influenza vaccine Arepanrix

Jan. 28, 2010

CHMP recommends suspension of marketing authorization for sibutramine

Jan. 26, 2010

EMEA recommends additional measures to manage risk for PML with Tysabri therapy

Jan. 26, 2010

Janssen-Cilag notifies EMEA of withdrawal of Comfyde MAA for partial-onset seizures

Jan. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...